At-211 PSMA-5
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for At-211 PSMA-5, covering 2025-07-31 to 2025-07-31. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial of Targeted Alpha Therapy Using [At-211]PSMA-5 for Prostate Cancer [Phase 1]